Kimberly-Clark bets $40 billion on Kenvue despite Tylenol controversy | REUTERS

Kimberly-Clark will buy Tylenol maker Kenvue for more than $40 billion in a historic deal that comes as the smaller company faces lawsuits over the painkiller, White House attacks and choppy demand.

#News #Reuters #Newsfeed #kimberlyclark #kenvue #tylenol

Read the story here: https://reut.rs/43MdvKn

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en

Post from Reuters on November 03, 2025

View Original Post